Evidence indicates increased BNIP3L promotes cardiomyocyte apoptosis and causes cardiomyopathy with LV dilation and represses systolic function, whereas reduced BNIP3L protects against apoptotic cardiomyopathy (Lynch et al., 2002; Diwan et al., 2008). Here, BNIP3L is linked to cardiomyopathy.